miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
about
MicroRNA Regulation of Epithelial to Mesenchymal TransitionMicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)Small non-coding RNAs govern mammary gland tumorigenesisRegulation of mesenchymal phenotype by MicroRNAs in cancerMicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potentialModeling of miRNA and drug action in the EGFR signaling pathwayMicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Trail resistance induces epithelial-mesenchymal transition and enhances invasiveness by suppressing PTEN via miR-221 in breast cancer.GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignanciesmiR-221/222 control luminal breast cancer tumor progression by regulating different targets.Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancerPairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees.Trps1 regulates biliary epithelial-mesenchymal transition and has roles during biliary fibrosis in liver grafts: a preliminary studymiR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1.Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysisNon-coding RNAs as regulators of mammary development and breast cancer.miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27(kip1.)Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review).Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells.Therapeutic evaluation of microRNAs by molecular imagingADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.MicroRNAs and epithelial-mesenchymal transition in prostate cancer.MicroRNA control of epithelial-mesenchymal transition and metastasis.Roles of microRNAs during prostatic tumorigenesis and tumor progression.MicroRNAs in cancer therapeutic response: Friend and foemicroRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Mir-221/222 are promising targets for innovative anticancer therapy.Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.The relationship between platinum drug resistance and epithelial-mesenchymal transition.Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.Naturally existing isoforms of miR-222 have distinct functions.miRNAs, Melanoma and Microenvironment: An Intricate Network.Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12.
P2860
Q26771110-220D346C-5D10-4F6D-87DB-6AEB8753CBBDQ26853284-946E26A0-4E32-4937-8930-2C6B87177EA6Q27007057-48BB60F4-421B-424A-A5AF-141BFC278B05Q27009506-CB5C6F6F-56F0-4ADD-B625-C770DCDEB06FQ28081081-2ED423F1-2A34-4AA0-B5F2-5E13077D5E7FQ28478852-9EDD821E-034B-4059-AB75-6988F8DD83C6Q33585094-C2A838FF-B3FE-4980-A417-33732393E27EQ33721556-05028305-4E06-4C55-B00D-F635AC75A175Q33798578-6E69B67E-CF28-4A1C-9DBE-0C46AF6766CAQ33952998-FA8843E3-FDA6-495E-B942-59383D20115CQ34273299-A7D55EE3-13E7-49B0-B691-223EAC79D1F5Q34490836-76A8AB26-E4E1-48A9-8418-E88F4DD266A0Q34494526-96C2D837-9D53-4FB0-9345-9D23D375EF38Q35461630-8CF4F4ED-6B1B-4B59-867E-FC03BE0AD70DQ35619205-23374A21-A101-4612-9C06-6AD090AEB360Q36172671-CC93A5E1-B928-419D-9863-141F73670F65Q36729649-E96CFA8A-1E12-4C82-B99A-00D7F589FB17Q36860719-A4FD8584-3F94-4663-A997-7C52BBD07D59Q36940253-1562EA2B-C9DD-41BE-836E-59AB40B82A4CQ37211756-0C0BBD49-F6BE-4C0A-820F-7931CC271455Q37278413-036308C2-22E0-406C-A3D5-D537A684D09DQ37313310-F02B0211-189D-4963-B200-06BD2798535EQ37344798-C847138D-A506-419C-AC04-0D1CD4B4D620Q37434627-19BC8C1A-82C7-4AFA-B105-F7B20AA25307Q37641594-1BDEB885-296A-4414-81A1-64E69F651118Q37643929-454C0C6C-57A4-44C6-A223-2DD720A46A6AQ37687205-F7D096D8-E6AA-4F4D-9260-B87ACA699653Q38017596-D05138EB-5E28-4F0A-A7C8-7140313D3EBEQ38086009-ECA9FE2D-8F3D-4385-80A0-F43FBC5C7BB2Q38258754-A439EF77-DDC6-4A12-81DE-2924F6A00944Q38336073-D4721812-7857-4178-B113-B5497BF704D2Q38767024-F52F102D-3B23-418E-9CDD-E8CB73932857Q39001625-9B065607-C1CE-41F2-BE13-5DF1BF1E4881Q39061847-7E57BFFC-EB2E-45C9-BAE5-717D59D2A54AQ41552639-C64C0247-F348-4721-8385-11A1C9F9CEF0Q41990770-CE4F40EF-2B4F-4DBE-AA0A-82670EDF2393Q47152593-701E5230-DA5B-48BB-B416-8E493E29BF79Q50057521-48E14702-25ED-497F-A839-F63B605C505AQ51415292-7ED59AF5-BA44-4F87-97ED-D5143298DBF3Q51419186-0C178D4D-2D5D-4DC8-8DB5-4563C151E3A7
P2860
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
miR-221/222 targeting of trich ...... l transition in breast cancer.
@en
miR-221/222 targeting of trichorhinophalangeal 1
@nl
type
label
miR-221/222 targeting of trich ...... l transition in breast cancer.
@en
miR-221/222 targeting of trichorhinophalangeal 1
@nl
prefLabel
miR-221/222 targeting of trich ...... l transition in breast cancer.
@en
miR-221/222 targeting of trichorhinophalangeal 1
@nl
P2093
P2860
P50
P1433
P1476
miR-221/222 targeting of trich ...... l transition in breast cancer.
@en
P2093
Alex T Adai
Carol O'Brien
David Dornan
Frederic J de Sauvage
Howard M Stern
Hyo-Jin Kim
Jill Spoerke
Lukas Amler
P2860
P356
10.1126/SCISIGNAL.2002258
P577
2011-08-09T00:00:00Z